awgldk
/
wikidata
/
Login
Register
TriplyDB
Wikidata
Browser
Table
SPARQL
Graphs
1
1
Services
1
1
Assets
0
0
Insights
Schema
BETA
Class frequency
Class hierarchy
Q44004556-03632FB4-5D1C-4AED-AF3B-E41A8A368C5B
Q44004556-03632FB4-5D1C-4AED-AF3B-E41A8A368C5B
BestRank
Statement
http://www.wikidata.org/entity/statement/Q44004556-03632FB4-5D1C-4AED-AF3B-E41A8A368C5B
Tissue factor and tissue factor pathway inhibitor levels in unstable angina patients during short-term low-molecular-weight heparin administration.
P2860
Q44004556-03632FB4-5D1C-4AED-AF3B-E41A8A368C5B
BestRank
Statement
http://www.wikidata.org/entity/statement/Q44004556-03632FB4-5D1C-4AED-AF3B-E41A8A368C5B
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
cae1f698e3f3cd353323ac95bc382903c3d11d75
P2860
Randomized trial of low molecular weight heparin (enoxaparin) versus unfractionated heparin for unstable coronary artery disease: one-year results of the ESSENCE Study. Efficacy and Safety of Subcutaneous Enoxaparin in Non-Q Wave Coronary Events.